Carin A. Uyl‐de Groot

445 total citations
25 papers, 271 citations indexed

About

Carin A. Uyl‐de Groot is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carin A. Uyl‐de Groot has authored 25 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carin A. Uyl‐de Groot's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Biomedical Ethics and Regulation (3 papers). Carin A. Uyl‐de Groot is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Biomedical Ethics and Regulation (3 papers). Carin A. Uyl‐de Groot collaborates with scholars based in Netherlands, United States and Spain. Carin A. Uyl‐de Groot's co-authors include C. René Leemans, Ken Redekop, Asaf Senft, Remco de Bree, Otto S. Hoekstra, Céline Louapre, Michel van Agthoven, Jasper J. Quak, Remco de Bree and Joost van Rosmalen and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Environmental Research and Public Health and Drugs.

In The Last Decade

Carin A. Uyl‐de Groot

23 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carin A. Uyl‐de Groot Netherlands 9 60 59 58 48 47 25 271
Martin Rolles United Kingdom 6 127 2.1× 55 0.9× 27 0.5× 39 0.8× 24 0.5× 13 252
Raetasha Dabney United States 7 103 1.7× 26 0.4× 5 0.1× 57 1.2× 14 0.3× 12 197
Annie Ellis United Kingdom 8 184 3.1× 40 0.7× 8 0.1× 69 1.4× 15 0.3× 15 335
Marta Venturelli Italy 9 161 2.7× 16 0.3× 27 0.5× 33 0.7× 27 0.6× 26 273
Chen‐Yuan Lin Taiwan 9 121 2.0× 148 2.5× 7 0.1× 84 1.8× 13 0.3× 24 333
Jia-Wei Lv China 7 138 2.3× 51 0.9× 11 0.2× 95 2.0× 27 0.6× 8 268
Gopal Bajaj United States 11 88 1.5× 129 2.2× 7 0.1× 127 2.6× 14 0.3× 21 286
Bassam Ghabach United States 6 139 2.3× 124 2.1× 6 0.1× 35 0.7× 55 1.2× 14 236
María José Lecumberri Spain 8 224 3.7× 46 0.8× 7 0.1× 93 1.9× 12 0.3× 14 333
Yuichiro Kikawa Japan 10 213 3.5× 26 0.4× 8 0.1× 103 2.1× 6 0.1× 57 284

Countries citing papers authored by Carin A. Uyl‐de Groot

Since Specialization
Citations

This map shows the geographic impact of Carin A. Uyl‐de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin A. Uyl‐de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin A. Uyl‐de Groot more than expected).

Fields of papers citing papers by Carin A. Uyl‐de Groot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carin A. Uyl‐de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin A. Uyl‐de Groot. The network helps show where Carin A. Uyl‐de Groot may publish in the future.

Co-authorship network of co-authors of Carin A. Uyl‐de Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Carin A. Uyl‐de Groot. A scholar is included among the top collaborators of Carin A. Uyl‐de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin A. Uyl‐de Groot. Carin A. Uyl‐de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Willemssen, François E.J.A., Rob A. de Man, Aad van der Lugt, et al.. (2024). Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study. European Radiology Experimental. 8(1). 29–29. 1 indexed citations
3.
Groot, Carin A. Uyl‐de, et al.. (2024). Legitimacy as Social Infrastructure: A Critical Interpretive Synthesis of the Literature on Legitimacy in Health and Technology. JMIR Human Factors. 12. e48955–e48955.
4.
Bas-Prior, Josep M Del, et al.. (2024). A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model. International Journal of Technology Assessment in Health Care. 40(1). e15–e15. 2 indexed citations
5.
Leeneman, B, Hedwig M. Blommestein, Willem E. Fibbe, et al.. (2023). Health‐related quality of life in patients with steroid‐refractory acute graft‐versus‐host disease. European Journal Of Haematology. 111(2). 240–246. 1 indexed citations
6.
Rosmalen, Joost van, et al.. (2023). Results from Expanded Access Programs: A Review of Academic Literature. Drugs. 83(9). 795–805. 2 indexed citations
7.
Luyendijk, Marianne, et al.. (2023). Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer. PharmacoEconomics. 41(8). 981–997. 5 indexed citations
8.
Luyendijk, Marianne, Otto Visser, Hedwig M. Blommestein, et al.. (2023). Changes in survival in de novo metastatic cancer in an era of new medicines. JNCI Journal of the National Cancer Institute. 115(6). 628–635. 22 indexed citations
9.
Veldwijk, Jorien, et al.. (2023). Preferences and willingness to pay for personalized nutrition interventions: Discrete choice experiments in Europe and the United States. Food Quality and Preference. 113. 105075–105075. 4 indexed citations
10.
Braal, C. Louwrens, et al.. (2022). Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands. Biomedicine & Pharmacotherapy. 158. 114158–114158. 2 indexed citations
11.
Roijen, Leona Hakkaart‐van, et al.. (2022). How Do Shifts in Patients with Mental Health Problems’ Formal and Informal Care Utilization Affect Informal Caregivers?: A COVID-19 Case Study. International Journal of Environmental Research and Public Health. 19(24). 16425–16425. 1 indexed citations
12.
Rosmalen, Joost van, et al.. (2022). Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals. BMJ Open. 12(1). e052186–e052186. 13 indexed citations
13.
Braal, C. Louwrens, Agnes Jager, Stijn L.W. Koolen, et al.. (2022). Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial. Clinical Drug Investigation. 42(2). 163–175. 5 indexed citations
14.
Simons, Martijn, Valesca P. Retèl, Bram Ramaekers, et al.. (2021). Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. PharmacoEconomics. 39(12). 1429–1442. 17 indexed citations
15.
Louapre, Céline, et al.. (2021). Health-related quality of life of multiple sclerosis patients: a European multi-country study. Archives of Public Health. 79(1). 39–39. 32 indexed citations
16.
17.
Groot, Carin A. Uyl‐de, Saskia de Groot, & Adri Steenhoek. (2010). The economics of improved cancer survival rates: better outcomes, higher costs. Expert Review of Pharmacoeconomics & Outcomes Research. 10(3). 283–292. 8 indexed citations
18.
Groot, Carin A. Uyl‐de, Asaf Senft, Remco de Bree, C. René Leemans, & Otto S. Hoekstra. (2010). Chest CT and Whole-Body18F-FDG PET Are Cost-Effective in Screening for Distant Metastases in Head and Neck Cancer Patients. Journal of Nuclear Medicine. 51(2). 176–182. 44 indexed citations
19.
Bree, Remco de, et al.. (2007). Free radial forearm flapversuspectoralis major myocutaneous flap reconstruction of oral and oropharyngeal defects: a cost analysis. Clinical Otolaryngology. 32(4). 275–282. 35 indexed citations
20.
Agthoven, Michel van, Carin A. Uyl‐de Groot, Pieter Sonneveld, et al.. (2002). Cost analysis of CHOP (‐like) chemotherapy regimens for patients with newly diagnosed aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 69(4). 213–220. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Rolles Breakdown of academic impact, for papers by Raetasha Dabney Breakdown of academic impact, for papers by Annie Ellis Breakdown of academic impact, for papers by Marta Venturelli Breakdown of academic impact, for papers by Chen‐Yuan Lin Breakdown of academic impact, for papers by Jia-Wei Lv Breakdown of academic impact, for papers by Gopal Bajaj Breakdown of academic impact, for papers by Bassam Ghabach Breakdown of academic impact, for papers by María José Lecumberri Breakdown of academic impact, for papers by Yuichiro Kikawa
Rankless by CCL
2026